Clinical Trials Browser

Phase 1/2 × Semaxinib × Gastrointestinal × Clear all

NCT00005818 2013-01-23

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms